Inner Ear Infections (Labyrinthitis)
Chapter
First Online:
Abstract
Infection of the inner ear, or labyrinthitis, can be caused by a variety of pathogens. The diagnosis is usually made based on the clinical findings of sensorineural hearing loss and/or vertigo in the setting of an ongoing infection, particularly otitis media or meningitis. It should be determined whether the causative agent is bacterial or viral so that appropriate treatment may be administered. The inner ear is exquisitely sensitive to insults such as infection, and in many cases the patient is left with permanent sensorineural hearing loss and vestibular dysfunction following an inner ear infection. Acute suppurative labyrinthitis can progress to intracranial infectious complications and requires prompt treatment.
Keywords
Labyrinthitis Inner ear Infection Ear Diagnosis Treatment Viral Bacterial Facial paralysisReferences
- 1.Cook RD, Postma DS, Brinson GM, Prazma J, Pillsbury HC. Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection. J Otolaryngol. 1999;28(6):325–31.PubMedGoogle Scholar
- 2.Ichimiya I, Suzuki M, Hirano T, Mogi G. The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res. 1999;131(1-2):128–34.CrossRefPubMedGoogle Scholar
- 3.Kawauchi H, DeMaria TF, Lim DJ. Endotoxin permeability through the round window. Acta Otolaryngol Suppl. 1989;457:100–15.PubMedGoogle Scholar
- 4.Tsuprun V, Cureoglu S, Schachern PA, Ferrieri P, Briles DE, Paparella MM, et al. Role of pneumococcal proteins in sensorineural hearing loss due to otitis media. Otol Neurotol. 2008;29(8):1056–60.CrossRefPubMedGoogle Scholar
- 5.Engel F, Blatz R, Schliebs R, Palmer M, Bhakdi S. Bacterial cytolysin perturbs round window membrane permeability barrier in vivo: possible cause of sensorineural hearing loss in acute otitis media. Infect Immun. 1998;66(1):343–6.PubMedCentralPubMedGoogle Scholar
- 6.Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. 1993;107(11):999–1004.CrossRefPubMedGoogle Scholar
- 7.Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003;113(10):1645–57.CrossRefPubMedGoogle Scholar
- 8.Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;(9):CD004405.Google Scholar
- 9.Hartnick CJ, Kim HH, Chute PM, Parisier SC. Preventing labyrinthitis ossificans: the role of steroids. Arch Otolaryngol Head Neck Surg. 2001;127(2):180–3.CrossRefPubMedGoogle Scholar
- 10.Philippon D, Bergeron F, Ferron P, Bussieres R. Cochlear implantation in postmeningitic deafness. Otol Neurotol. 2010;31(1):83–7.CrossRefPubMedGoogle Scholar
- 11.Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect. 2016;73(1):18–27.CrossRefPubMedGoogle Scholar
- 12.Merchant SN, Gopen Q. A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol. 1996;17(3):375–85.PubMedGoogle Scholar
- 13.Devriese PP. Facial paralysis in cephalic herpes zoster. Ann Otol Rhinol Laryngol. 1968;77(6):1101–19.CrossRefPubMedGoogle Scholar
- 14.Coulson S, Croxson GR, Adams R, Oey V. Prognostic factors in herpes zoster oticus (ramsay hunt syndrome). Otol Neurotol. 2011;32(6):1025–30.CrossRefPubMedGoogle Scholar
- 15.Devriese PP, Moesker WH. The natural history of facial paralysis in herpes zoster. Clin Otolaryngol Allied Sci. 1988;13(4):289–98.CrossRefPubMedGoogle Scholar
- 16.Robillard RB, Hilsinger RL Jr, Adour KK. Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol Head Neck Surg. 1986;95(3 Pt 1):292–7.CrossRefPubMedGoogle Scholar
- 17.Nadol JBJ, Infections L. In: Merchant SN, Nadol JBJ, editors. Schuknecht’s pathology of the ear. 3rd ed. Beijing: People’s Medical Publishing House; 2010. p. 309.Google Scholar
- 18.Al-Hussaini A, Latif F, Berry S. Ear pain, vesicular rash, and facial palsy. BMJ. 2014;349:g7572.CrossRefPubMedGoogle Scholar
- 19.Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972–82.CrossRefPubMedGoogle Scholar
- 20.Duval M, Park AH. Congenital cytomegalovirus: what the otolaryngologist should know. Curr Opin Otolaryngol Head Neck Surg. 2014;22(6):495–500.CrossRefPubMedGoogle Scholar
- 21.Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135(1):60–4.CrossRefPubMedGoogle Scholar
- 22.Harris JP, Fan JT, Keithley EM. Immunologic responses in experimental cytomegalovirus labyrinthitis. Am J Otolaryngol. 1990;11(5):304–8.CrossRefPubMedGoogle Scholar
- 23.Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW Jr, Palmer AL, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303(14):1375–82.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16–25.CrossRefGoogle Scholar
- 26.Kimberlin DW, Jester PM, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372(10):933–43.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Centers for Disease Control and Prevention (CDC). Measles. Available at: http://www.cdc.gov/measles/hcp/index.html. Accessed October 2017.Google Scholar
- 28.Rima BK, Duprex WP. Morbilliviruses and human disease. J Pathol. 2006;208(2):199–214.CrossRefPubMedGoogle Scholar
- 29.Arnold W, Niedermeyer HP, Lehn N, Neubert W, Hofler H. Measles virus in otosclerosis and the specific immune response of the inner ear. Acta Otolaryngol. 1996;116(5):705–9.CrossRefPubMedGoogle Scholar
- 30.Karosi T, Konya J, Szabo LZ, Sziklai I. Measles virus prevalence in otosclerotic stapes footplate samples. Otol Neurotol. 2004;25(4):451–6.CrossRefPubMedGoogle Scholar
- 31.McKenna MJ, Mills BG, Galey FR, Linthicum FH Jr. Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am J Otol. 1986;7(1):25–8.PubMedGoogle Scholar
- 32.McKenna MJ, Mills BG. Immunohistochemical evidence of measles virus antigens in active otosclerosis. Otolaryngol Head Neck Surg. 1989;101(4):415–21.CrossRefPubMedGoogle Scholar
- 33.McKenna MJ, Mills BG. Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis. Acta Otolaryngol Suppl. 1990;470:130–9. discussion 139–40.PubMedGoogle Scholar
- 34.McKenna MJ, Kristiansen AG, Haines J. Polymerase chain reaction amplification of a measles virus sequence from human temporal bone sections with active otosclerosis. Am J Otol. 1996;17(6):827–30.PubMedGoogle Scholar
- 35.Niedermeyer H, Arnold W, Neubert WJ, Hofler H. Evidence of measles virus RNA in otosclerotic tissue. ORL J Otorhinolaryngol Relat Spec. 1994;56(3):130–2.CrossRefPubMedGoogle Scholar
- 36.Niedermeyer HP, Arnold W. Otosclerosis: a measles virus associated inflammatory disease. Acta Otolaryngol. 1995;115(2):300–3.CrossRefPubMedGoogle Scholar
- 37.Niedermeyer HP, Arnold W, Schuster M, Baumann C, Kramer J, Neubert WJ, et al. Persistent measles virus infection and otosclerosis. Ann Otol Rhinol Laryngol. 2001;110(10):897–903.CrossRefPubMedGoogle Scholar
- 38.Bordley JE. Editorial. The effect of viral infection on hearing. A state-of-the-art report with special emphasis on congenital rubella. Arch Otolaryngol. 1973;98(4):217.CrossRefPubMedGoogle Scholar
- 39.Hardy JB. Fetal consequences of maternal viral infections in pregnancy. Arch Otolaryngol. 1973;98(4):218–27.CrossRefPubMedGoogle Scholar
- 40.Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev. 2000;13(4):571–87.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Barr B, Lundstrom R. Deafness following maternal rubella. Retrospective and prospective studies. Acta Otolaryngol. 1961;53:413–23.CrossRefPubMedGoogle Scholar
- 42.Burgess RC, Michaels L, Bale JF Jr, Smith RJ. Polymerase chain reaction amplification of herpes simplex viral DNA from the geniculate ganglion of a patient with Bell’s palsy. Ann Otol Rhinol Laryngol. 1994;103(10):775–9.CrossRefPubMedGoogle Scholar
- 43.Furuta Y, Fukuda S, Chida E, Takasu T, Ohtani F, Inuyama Y, et al. Reactivation of herpes simplex virus type 1 in patients with Bell’s palsy. J Med Virol. 1998;54(3):162–6.CrossRefPubMedGoogle Scholar
- 44.Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1 Pt 1):27–30.CrossRefPubMedGoogle Scholar
- 45.Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1–27.CrossRefPubMedGoogle Scholar
- 46.Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med. 2007;357:1598–607.CrossRefPubMedGoogle Scholar
- 47.Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, et al. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2015;(11):CD001869.Google Scholar
- 48.Smouha E, Toh E, Schaitkin BM. Surgical treatment of Bell’s palsy: current attitudes. Laryngoscope. 2011;121(9):1965–70.PubMedGoogle Scholar
- 49.Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell’s palsy. Laryngoscope. 1999;109(8):1177–88.CrossRefPubMedGoogle Scholar
- 50.Cannon RB, Gurgel RK, Warren FM, Shelton C. Facial nerve outcomes after middle fossa decompression for Bell’s palsy. Otol Neurotol. 2015;36(3):513–8.CrossRefPubMedGoogle Scholar
- 51.Diehl GE, Holtmann S. Lyme borreliosis and its significance for the ENT physician. Laryngorhinootologie. 1989;68(2):81–7.CrossRefPubMedGoogle Scholar
- 52.Bradshaw D, Pallawela S, Nelson M, Scott C, Day S. Otosyphilis: missed opportunities for early treatment? Sex Transm Infect. 2012;88(8):573.CrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG, part of Springer Nature 2018